Search Results - "Tierney, Brent J"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer by RATH, Kellie S, NAIDU, Shan K, HOUGHTON, Peter, HIDEG, Kálmán, KUPPUSAMY, Periannan, COHN, David E, SELVENDIRAN, Karuppaiyah, LATA, Pushpa, BID, Hemant K, RIVERA, Brian K, MCCANN, Georgia A, TIERNEY, Brent J, ELNAGGAR, Adam C, BRAVO, Veronica, LEONE, Gustavo

    Published in Cancer research (Chicago, Ill.) (15-04-2014)
    “…STAT3 is well corroborated preclinically as a cancer therapeutic target, but tractable translational strategies for its blockade by small molecule inhibitors…”
    Get full text
    Journal Article
  2. 2

    HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells by Tierney, Brent J., McCann, Georgia A., Cohn, David E., Eisenhauer, Eric, Sudhakar, Meryl, Kuppusamy, Periannan, Hideg, Kálmán, Selvendiran, Karuppaiyah

    Published in Cancer biology & therapy (01-07-2012)
    “…BRCA1 plays an important role in DNA damage and repair, homologous recombination, cell-cycle regulation and apoptosis. BRCA-mutated ovarian cancer often…”
    Get full text
    Journal Article
  3. 3

    Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor by Tierney, Brent J, McCann, Georgia A, Naidu, Shan, Rath, Kellie S, Saini, Uksha, Wanner, Ross, Kuppusamy, Periannan, Suarez, Adrian, Goodfellow, Paul J, Cohn, David E, Selvendiran, Karuppaiyah

    Published in Gynecologic oncology (01-10-2014)
    “…Abstract Objective Constitutive activation of STAT3 is a hallmark of various human cancers, however an increased pSTAT3 expression in high grade human…”
    Get full text
    Journal Article
  4. 4

    Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor by McCann, Georgia A, Naidu, Shan, Rath, Kellie S, Bid, Hemant K, Tierney, Brent J, Suarez, Adrian, Varadharaj, Saradhadevi, Zhang, Jianying, Hideg, Kálmán, Houghton, Peter, Kuppusamy, Periannan, Cohn, David E, Selvendiran, Karuppaiyah

    Published in Oncoscience (31-03-2014)
    “…Tumor hypoxia, a feature of many solid tumors including ovarian cancer, is associated with resistance to therapies. We previously demonstrated that hypoxic…”
    Get full text
    Journal Article
  5. 5

    Infantile Myofibromatosis: A Nontraumatic Cause of Neonatal Brachial Plexus Palsy by Tierney, Travis S., MD, DPhil, Tierney, Brent J., MD, Rosenberg, Andrew E., MD, Krishnamoorthy, Kalpathy S., MD, Butler, William E., MD

    Published in Pediatric neurology (01-10-2008)
    “…Most injuries to the neonatal brachial plexus occur acutely at birth, and are iatrogenic in origin. However, when weakness is accompanied by atrophy,…”
    Get full text
    Journal Article
  6. 6

    Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo by Tierney, Brent J., Ho, Trang, Reedy, Mark V., Brauer, Philip R.

    Published in Developmental dynamics (01-01-2004)
    “…Elevated homocysteine increases the risk of neurocristopathies. Here, we determined whether elevating homocysteine altered the proliferation or number of chick…”
    Get full text
    Journal Article
  7. 7

    Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: Time to change back? by Backes, Floor J, Tierney, Brent J, Eisenhauer, Eric L, Bahnson, Robert R, Cohn, David E, Fowler, Jeffrey M

    Published in Gynecologic oncology (01-01-2013)
    “…Abstract Objective To assess complications associated with double-barreled wet colostomy (DBWC) in the first six months after pelvic exenteration as compared…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Abstract POSTER-THER-1413: Targeting constitutively-activated STAT3 in hypoxic ovarian cancer by McCann, Georgia A, ElNaggar, Adam, Naidu, Shan, Rath, Kellie S, Tierney, Brent J, Suarez, Adrian, Cohn, David E, Selvendiran, Karuppaiyah

    Published in Clinical cancer research (15-08-2015)
    “…Abstract Background: Tumor hypoxia, a feature of many solid tumors including ovarian cancer, is associated with resistance to therapies. We previously…”
    Get full text
    Journal Article
  10. 10

    Abstract 2032: Inhibition of signal transducers and activators of transcription 3 in human endometrial cancer, using a novel STAT3 inhibitor by Tierney, Brent J., McCann, Georgia A., Rath, Kellie S., Sudhakar, Meryl, Naidu, Shan, Kuppusamy, Periannan, Cohn, David E., Selvendiran, Karuppaiyah

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract OBJECTIVE: Signal transducer and activator of transcription 3 (Stat3) proteins have important roles in cancer cell survival and proliferation. Recent…”
    Get full text
    Journal Article
  11. 11

    Abstract 2802: Selective inhibition of signal transducers and activators of transcription 3 overexpressing endometrial cancer cells, using HO-3867, a novel STAT3 inhibitor by McCann, Georgia, Tierney, Brent J., Cohn, David, Sudhakar, Meryl, Naidu, Shan, Eisenhauer, Eric, Karuppaiyah, Selvendiran

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract OBJECTIVE: Signal transducer and activator of transcription 3 (STAT3) proteins have important roles in cancer cell survival and proliferation. Recent…”
    Get full text
    Journal Article
  12. 12

    Abstract 4723: HO-3867, a STAT3 inhibitor induces G2/M arrest and apoptosis in BRCA1-mutated ovarian cancer cells by Tierney, Brent J., McCann, Georgia, Cohn, David E., Sudhakar, Meryl, O'Malley, David, Karuppaiyah, Selvendiran

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract Background: BRCA1 plays an important role in DNA damage and repair, homologous recombination, cell-cycle regulation, and apoptosis. BRCA-mutated…”
    Get full text
    Journal Article
  13. 13

    Abstract 3940: Activation of Signal Transducer and Activator of Transcription 3 (STAT3) in ovarian cancer: The hypoxic implications by McCann, Georgia A., Naidu, Shan, Tierney, Brent J., Sudhakar, Meryl, Cohn, David E., Selvendiran, Karuppaiyah

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract Background: The hypoxic microenvironment plays a key role in tumorigenesis and the development of therapeutic resistance in epithelial ovarian cancer…”
    Get full text
    Journal Article
  14. 14